CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | 0.0% | 10,500 | 0.0% | 0.03% | +100.0% |
| Q1 2022 | $21,000 | -80.9% | 10,500 | -58.1% | 0.01% | -53.3% |
| Q4 2021 | $110,000 | +8.9% | 25,070 | +9.0% | 0.03% | +3.4% |
| Q3 2021 | $101,000 | -22.3% | 23,000 | -3.2% | 0.03% | -45.3% |
| Q2 2021 | $130,000 | -16.1% | 23,750 | 0.0% | 0.05% | +10.4% |
| Q1 2021 | $155,000 | +36.0% | 23,750 | 0.0% | 0.05% | -2.0% |
| Q4 2020 | $114,000 | -19.1% | 23,750 | -2.1% | 0.05% | -22.2% |
| Q3 2020 | $141,000 | -13.0% | 24,250 | +0.8% | 0.06% | -7.4% |
| Q2 2020 | $162,000 | +36.1% | 24,050 | +29.6% | 0.07% | +28.3% |
| Q1 2020 | $119,000 | +4.4% | 18,550 | +67.9% | 0.05% | +26.2% |
| Q4 2019 | $114,000 | – | 11,050 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |